Skip to content

Synthes Acis/Vertebral Spacer Cr

by Synthes USA, LLC

510(k) K120275

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK120275 Date25 May 2012ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
ODP
FDA applicant
Synthes (Usa), LLC
Device Class
Class II
Regulation
21 CFR Part 888.3080
Advisory Committee
Orthopedic
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 22 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Synthes ACIS and Vertebral Spacer CR are radiolucent cervical intervertebral body fusion devices. These implants are designed to be inserted within the intervertebral disc space to provide structural stability in skeletally mature individuals with degenerative disc disease.

The devices are implanted via an anterior approach and are intended to be used with supplemental fixation. The interior of the spacer is packed with autogenous bone graft to facilitate fusion. This device has received FDA 510(k) clearance.

Other devices from Synthes (Usa)

See all devices from Synthes (Usa) →

Questions

AI-generated answers, 22 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the intended use of the Synthes ACIS/Vertebral Spacer CR?

    This device is a radiolucent cervical intervertebral body fusion implant designed to provide structural stability within the intervertebral disc space for skeletally mature individuals diagnosed with degenerative disc disease.

  • How is the Synthes ACIS/Vertebral Spacer CR implanted?

    The device is implanted using an anterior surgical approach. It is intended to be used in conjunction with supplemental fixation to ensure proper stability during the fusion process.

  • How is the fusion process supported by this device?

    To facilitate the fusion process, the interior of the spacer is designed to be packed with autogenous bone graft, which encourages bone growth and structural integration within the disc space.

  • What is the regulatory status of this device?

    The Synthes ACIS and Vertebral Spacer CR has received FDA 510(k) clearance, which indicates that the device has been determined to be substantially equivalent to legally marketed predicate devices.